Tissium is a series c plus startup based in France. 3 investors tracked.
Tissium is a startup founded in 2013 based in France. Its most recent tracked round is Series-c-plus. Brouky records 5 investors associated with the company.
Tissium develops biomorphic programmable polymers for tissue reconstruction, enabling solutions for peripheral nerve repair, hernia treatment, and cardiovascular applications through its proprietary polymer platform.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.